Cancer Biology & Medicine (Dec 2018)
2017 Chinese expert consensus on the clinical application of serum marker for thyroid cancer
- Ming Gao,
- Minghua Ge,
- Qinghai Ji,
- Ruochuan Cheng,
- Hankui Lu,
- Haixia Guan,
- Wei Cui,
- Li Gao,
- Zairong Gao,
- Lin Guo,
- Zhuming Guo,
- Tao Huang,
- Xiaoming Huang,
- Yansong Lin,
- Qinjiang Liu,
- Xin Ni,
- Jianwu Qin,
- Li Ren,
- Zhongyan Shan,
- Hui Sun,
- Xudong Wang,
- Zhengang Xu,
- Yang Yu,
- Bin Zhang,
- Daiwei Zhao,
- Ying Zheng,
- Jingqiang Zhu,
- Xiangqian Zheng,
- Chinese Association of Thyroid Oncology (CATO),
- China Anti-Cancer Association
Affiliations
- Ming Gao
- Department of Head and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital; National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China;
- Minghua Ge
- Department of Head and Neck, Zhejiang Cancer Hospital, Hangzhou 310022, China;
- Qinghai Ji
- Department of Head and Neck Tumor, Fudan University Shanghai Cancer Center, Shanghai 200433, China;
- Ruochuan Cheng
- Department of General Surgery, First Affiliated Hospital of Kunming Medical University, Kunming 650032, China;
- Hankui Lu
- Department of Nuclear Medicine, The Sixth Affiliated Hospital of Shanghai Jiao Tong University, Shanghai 200025, China;
- Haixia Guan
- Department of Endocrinology, The First Hospital of China Medical University, Shenyang 110001, China;
- Wei Cui
- Department of Clinical Laboratory, Cancer Hospital Chinese Academy of Medical Science, Beijing 100021, China;
- Li Gao
- Department of Head and Neck, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310020, China;
- Zairong Gao
- Department of Nuclear Medicine, Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan 430030, China;
- Lin Guo
- Department of Clinical Laboratory, Fudan University Shanghai Cancer Center, Shanghai 200433, China;
- Zhuming Guo
- Sun Yat-sen University Cancer Center, Guangzhou 510060, China;
- Tao Huang
- Department of Thyroid and Breast, Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan 430030, China;
- Xiaoming Huang
- Department of Otolaryngology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China;
- Yansong Lin
- Department of Nuclear Medicine, Peking Union Medical College Hospital, Beijing 100730, China;
- Qinjiang Liu
- Department of Head and Neck, Gansu Provincial Cancer Hospital, Lanzhou 730050, China;
- Xin Ni
- Department of Head and Neck, Beijing Children’s Hospital, Capital Medical University, Beijing 100045, China;
- Jianwu Qin
- Department of Thyroid, Head and Neck, Henan Cancer Hospital, Zhengzhou 450008, China;
- Li Ren
- Department of Clinical Laboratory, Tianjin Medical University Cancer Institute and Hospital; National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China;
- Zhongyan Shan
- Department of Endocrinology, The First Hospital of China Medical University, Shenyang 110001, China;
- Hui Sun
- Department of Thyroid, Sino Japanese Union Hospital of Jilin University, Changchun 130033, China;
- Xudong Wang
- Department of Head and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital; National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China;
- Zhengang Xu
- Department of Head and Neck, Cancer Hospital Chinese Academy of Medical Sciences, Beijing 100021, China;
- Yang Yu
- Department of Head and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital; National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China;
- Bin Zhang
- Department of Head and Neck, Peking Union Medical College Hospital, Beijing 100730, China;
- Daiwei Zhao
- Department of General Surgery, The Second Affiliated Hospital of Guizhou Medical University, Kaili 556099, China;
- Ying Zheng
- Department of Head and Neck, Jilin Tumor Hospital, Changchun 130012, China;
- Jingqiang Zhu
- Department of Thyroid and Breast, West China School of Medicine, West China Hospital, Sichuan University, Chengdu 610047, China
- Xiangqian Zheng
- Department of Head and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital; National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China;
- Chinese Association of Thyroid Oncology (CATO)
- Department of Head and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital; National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China;
- China Anti-Cancer Association
- Department of Head and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital; National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China;
- DOI
- https://doi.org/10.20892/j.issn.2095-3941.2018.0084
- Journal volume & issue
-
Vol. 15,
no. 4
pp. 468 – 477
Abstract
No abstracts available.